The pharmaceutical industry seems besieged on all sides by declining R&D productivity, expiring patents and relentless downward pricing pressure. One effect of this onslaught has been an upsurge in the level of consolidation as industry players attempt to cut costs, expand research pipelines and lengthen geographic reach.
11-Jun-2012 - S&P thinks PRA will use the flexibility in its new credit facility to grow its business through acquisitions.
07-Jun-2012 - inVentiv Health will expand its digital and social media commercial services following the takeover of Kazaam Interactive.
05-Jun-2012 - Outsourcing-Pharma presents a roundup of M&A activity in the CMO space, including Piramal on the hunt for deals and Siegfried buying AMP.
29-May-2012 - Kemwell is set to complete a new biologics manufacturing facility in Bangalore, India, following its long-term partnership with Boehringer Ingelheim.
28-May-2012 - More than a third of patient recruitment will be done in emerging markets in the future, predicts Chiltern CEO Glenn Kerkhof.
21-May-2012 - The CEO of PDI said the contract sales market has “shrunk” over the past few quarters as the flow of business awards has dried up.
09-May-2012 - Increased oversight by the FDA is causing some US-based CMOs to shut down, a speaker at Interphex said.
07-May-2012 - The CEO of Charles River said asset transfer strategic deals make little “rational sense” to clients or CROs.
25-Apr-2012 - The European CMO industry could be blocked by over complex layers of regulation, says Frost & Sullivan analyst Aiswariya Chidambaram.
05-Apr-2012 - Regulatory reform was the name of the game at this year’s DIA Euromeeting in Denmark.
03-Apr-2012 - Sigma-Aldrich plans to grow its new biologics toxicology services unit by creating targeted cell lines and animal models.
03-Apr-2012 - INC Research and inVentiv Health must “quickly and effectively” integrate acquisitions to compete with other CROs, S&P said.
29-Mar-2012 - “Less bureaucracy and more research” was the Danish Minister of science and innovation’s message to regulators at this week's DIA Euromeeting.
29-Mar-2012 - Cetero says it could have new private equity owners in 90 days and an agreed path forward with the FDA in weeks.
19-Mar-2012 - A SEC filing has created speculation that Medidata is the target of a private equity takeover attempt by Vista Equity Partners.
15-Mar-2012 - The European CMO sector is set to double in the next six years and will hit revenues of up to $20.75bn, according to Frost & Sullivan’s Aiswariya Chidambaram.
13-Mar-2012 - Patheon took a $20.9m (€15.9m) Q1 hit in operating costs thanks to the loss of a major manufacturing supply agreement.
14-Feb-2012 - SeraCare Life Sciences has accepted an $82m offer from a US private equity firm six months after it began searching for a buyer.
07-Feb-2012 - Covance is investing to win business from “distracted competitors” that have been part of mergers and buyouts, an analyst claims.
24-Jan-2012 - Preclinical CROs begin reporting full year results this week, with talk of takeovers and toxicology high on agendas.
24-Jan-2012 - Outsourcing is a gamble for the industry that needs a closer collaborative approach if pharma firms want a successful performance, according to new research.
23-Jan-2012 - UK-based Polytherics has acquired Warwick Effect Polymers (WEP) to expand biologic drug modification offering.
12-Jan-2012 - Charles River’s CEO has reiterated the importance of integrating its research models and preclinical units but refused to discuss takeover reports.
11-Jan-2012 - Major CRO consolidation will slow down in 2012 after the big wave of deals last year, the CEO of Icon said.
10-Jan-2012 - Charles River is reportedly considering selling the business, with private equity and rival companies believed to be possible buyers.